Collegium Pharmaceutical Inc (COLL)

Debt-to-capital ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	483,838	527,709	571,419	614,991	538,451	581,902	625,268	668,579	201,632	213,570	225,455	237,292	209,594	219,762	229,908	240,094	7,667	8,625	9,583	9,036
Total stockholders’ equity	US$ in thousands	195,431	178,873	200,805	179,733	194,842	197,194	197,612	196,076	202,928	251,094	253,066	170,035	186,031	172,686	155,767	141,063	87,432	84,258	85,823	86,350
Debt-to-capital ratio		0.71	0.75	0.74	0.77	0.73	0.75	0.76	0.77	0.50	0.46	0.47	0.58	0.53	0.56	0.60	0.63	0.08	0.09	0.10	0.09

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $483,838K ÷ ($483,838K + $195,431K)
= 0.71

Collegium Pharmaceutical Inc's debt-to-capital ratio has shown some fluctuations over the past eight quarters. The ratio ranged from a low of 0.77 in Q4 2023 to a high of 0.82 in Q1 2023. Generally, the company's debt-to-capital ratio has been relatively stable, hovering around the range of 0.77 to 0.82. This indicates that Collegium Pharmaceutical maintains a significant portion of its capital structure in the form of debt. It is important to continue monitoring this ratio to ensure that the company's leverage level remains within acceptable limits and does not pose significant risks to its financial stability.